Tag: nalmefene
Now the FDA Wants Nalmefene to Be a Fentanyl-Exposure “Prophylactic”
The Food and Drug Administration is reportedly providing guidance and “positive feedback” for a ...
MA Overdose Bills Signal Push Toward Nalmefene, Civil Commitment
Massachusetts is considering multiple proposals that, taken together, would make the landscape of overdose ...
Indivior Isn’t Done With Opvee, the Overdose Antidote That’s Not Narcan
Less than two months after an investigation into deceptive marketing prompted Indivior Inc. to ...
Opvee, High-Profile Overdose Antidote No One Used, Discontinues Marketing
Indivior PLC has discontinued marketing for Opvee, the opioid-overdose reversal product that the pharmaceutical ...
Indivior-Funded Study Suggests Opvee Outperforms Narcan. But at What?
Indivior PLC, the pharmaceutical company that manufactures the opioid overdose antidote Opvee (nalmefene), has ...
Fentanyl Doomsday Prepping
On August 26, pharmaceutical manufacturer Indivior announced that it had begun supplying the Biomedical ...
FDA Approves Risky Opioid Overdose Reversal Product From Purdue Pharma
On August 7 the Food and Drug Administration approved an opioid overdose antidote developed ...
Nalmefene Is Not “Just Like Naloxone”
Opvee, an opioid-overdose antidote manufactured by Indivior that was approved in 2023, has in ...
